Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Skin Tear, Solar Purpura, Dermatoporosis
In brief
The purpose of this research is to determine whether once nightly application of tretinoin 0.1% cream to forearm skin reduces the frequency of skin tears and bruising (solar purpura), and changes skin thickness over a period of 6 months.
Key facts
- Study ID
- NCT07084116
- Run by
- James Thomas Pathoulas
- People needed
- 15
- Starts
- 2025-07-14
- Expected to finish
- 2026-05-24
- Last updated by the study team
- 2026-05-28
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult (55+)
- History of skin tears, at least 2 in the past month
- History of skin bruising (solar purpura)
- Ambulatory
- Able to apply topical medication to oneself
You may not qualify if…
- <55 years old)
- Pregnant or breastfeeding
- History of allergy to tretinoin
- History of atopic dermatitis, psoriasis, bullous skin disease, cutaneous lupus, or cutaneous T cell lymphoma.
- Planned cutaneous surgery on either forearm in the next 6 months
- Use of any topical medication on the forearms within past month
- Current or anticipated phototherapy of the forearms in the next 6 months
- Current or anticipated chemotherapy within the next 6 months
- Use of oral steroids within past month
- Current or prior isotretinoin therapy within past 6 months
- AV fistula of the arm
Where it is running
- Palo Alto VA Medical Center — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.